Primary human mesothelioma cells express class II MHC, ICAM-1 and B7-2 and can present recall antigens to autologous blood lymphocytes.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 9833768)

Published in Int J Cancer on December 09, 1998

Authors

L Mutti1, M T Valle, B Balbi, A M Orengo, A Lazzaro, P Alciato, E Gatti, P G Betta, E Pozzi

Author Affiliations

1: S. Maugeri Foundation, Institute for Research and Care, Pavia, Italy. cdl@intercom.it

Articles by these authors

Developmental regulation of MHC class II transport in mouse dendritic cells. Nature (1997) 5.17

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med (1993) 3.59

Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J (1999) 2.70

Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med (1992) 2.69

Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J (2004) 2.07

A rat brain Sec1 homologue related to Rop and UNC18 interacts with syntaxin. Proc Natl Acad Sci U S A (1994) 2.07

Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans. J Exp Med (1992) 2.04

CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J Exp Med (1991) 1.96

T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol (2009) 1.89

Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health (1989) 1.81

Physiological analysis of mutants indicates involvement of the Saccharomyces cerevisiae GPI-anchored protein gp115 in morphogenesis and cell separation. J Bacteriol (1993) 1.71

Isolation and deduced amino acid sequence of the gene encoding gp115, a yeast glycophospholipid-anchored protein containing a serine-rich region. J Biol Chem (1991) 1.63

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Results on neutrinoless double-β decay of 76Ge from phase I of the GERDA experiment. Phys Rev Lett (2013) 1.54

Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J (1998) 1.50

Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis. J Clin Invest (1988) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Effect of rifampicin on delayed-hypersensitivity reactions. J Infect Dis (1972) 1.31

Tele-assistance in chronic respiratory failure patients: a randomised clinical trial. Eur Respir J (2008) 1.29

T-lymphocytes with gamma delta+ V delta 2+ antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis. Am Rev Respir Dis (1993) 1.28

Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol (1995) 1.28

Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection. Am Rev Respir Dis (1987) 1.25

What defines airflow obstruction in asthma? Eur Respir J (2009) 1.22

Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics. Eur Respir J (1999) 1.22

Identification and characterization of homologues of the Exocyst component Sec10p. FEBS Lett (1997) 1.20

Specific interactions of Mss4 with members of the Rab GTPase subfamily. EMBO J (1994) 1.19

Yeast protein translocation complex: isolation of two genes SEB1 and SEB2 encoding proteins homologous to the Sec61 beta subunit. Yeast (1996) 1.16

Mesodermomas: a new embryological approach to primary tumours of coelomic surfaces. Histopathology (1981) 1.15

Limited clonal heterogeneity of antigen-specific T cells localizing in the pleural space during mycobacterial infection. Infect Immun (1991) 1.08

Precise measurement of the e+e- --> pi+pi-(gamma) cross section with the initial state radiation method at BABAR. Phys Rev Lett (2009) 1.07

Plasmapheresis for treatment of pulmonary alveolar proteinosis. Eur Respir J (2009) 1.05

Measurement of |V(cb)| and the form-factor slope in B --> Dl- nu(l) decays in events tagged by a fully reconstructed B meson. Phys Rev Lett (2010) 1.05

Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis. Eur Respir J (1999) 1.05

MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J (2000) 1.04

Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. Vaccine (1994) 1.03

Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD. Thorax (2009) 1.03

Prognostic significance of Ki67 labelling in resected non small cell lung cancer. Eur J Cancer (1993) 1.03

Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene (1996) 1.02

Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. Clin Exp Allergy (2001) 1.01

Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur Respir J (2004) 1.01

Human ciliated bronchial epithelial cells: expression of the HLA-DR antigens and of the HLA-DR alpha gene, modulation of the HLA-DR antigens by gamma-interferon and antigen-presenting function in the mixed leukocyte reaction. Am J Respir Cell Mol Biol (1990) 1.00

[Benign cystic mesothelioma of the peritoneum]. G Ital Oncol (1989) 1.00

Focal liver lesions in non-Hodgkin's lymphoma: investigation of their prevalence, clinical significance and the role of Hepatitis C virus infection. Eur J Cancer (2002) 1.00

Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia. Lancet (1977) 0.99

EuCliD (European Clinical Database): a database comparing different realities. J Nephrol (2002) 0.99

Soy and cholesterol reduction: clinical experience. J Nutr (1995) 0.99

Verification of the histologic diagnosis of malignant mesothelioma in relation to the binding of an antimesothelial cell antibody. Cancer (1989) 0.99

OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol (2009) 0.98

Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet (2005) 0.97

Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96

The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. Int J Tuberc Lung Dis (2003) 0.94

T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor. Am Rev Respir Dis (1992) 0.94

Malignant mesothelioma of the pleura: interobserver variability. J Clin Pathol (1995) 0.93

Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis. Eur J Histochem (2007) 0.92

Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis. Am Rev Respir Dis (1991) 0.92

Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur Respir J (2003) 0.91

Home mechanical ventilation patients: a retrospective survey to identify level of burden in real life. Monaldi Arch Chest Dis (2007) 0.91

Helper T-lymphocytes in pulmonary sarcoidosis. Functional analysis of a lung T-cell subpopulation in patients with active disease. Am Rev Respir Dis (1986) 0.90

Testis sparing enucleation of a Leydig-cell tumour in a boy. Pediatr Med Chir (2003) 0.90

Telemedicine: a new frontier for effective healthcare services. Monaldi Arch Chest Dis (2005) 0.90

Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J (2006) 0.89

New irradiation facility for biomedical applications at the RA-3 reactor thermal column. Appl Radiat Isot (2009) 0.88

HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity. J Immunol (1998) 0.88

Evolutionary conservation of genomic sequences related to the GGP1 gene encoding a yeast GPI-anchored glycoprotein. Curr Genet (1993) 0.88

Ovarian mesothelial tumors and herbicides: a case-control study. Carcinogenesis (1984) 0.87

Putative mesothelial cell growth-promoting activity of a cytoplasmic protein expressed by the mesothelial cell. A preliminary report. Exp Cell Biol (1989) 0.87

Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur J Immunol (1995) 0.87

Preferential usage of the T-cell antigen receptor beta-chain constant region C beta 1 element by lung T-lymphocytes of patients with pulmonary sarcoidosis. Am Rev Respir Dis (1991) 0.86

HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines. Eur J Immunol (2000) 0.86

High-Resolution High-Count-Rate X-ray Spectroscopy with State-of-the-Art Silicon Detectors. J Synchrotron Radiat (1998) 0.86

Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res Ther (2006) 0.86

Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients. Lung Cancer (2001) 0.86

EuCliD--a medical registry. Methods Inf Med (2004) 0.86

Repertoire breadth of human CD4+ T cells specific for HIV gp120 and p66 (primary antigens) or for PPD and tetanus toxoid (secondary antigens) Hum Immunol (1998) 0.85

Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha. Eur Respir J (2008) 0.85

Analysis of natural killer (NK) cell subsets defined by the expression of two novel surface antigens (EB6 and GL183) in AIDS and AIDS-related conditions. Clin Immunol Immunopathol (1994) 0.85

Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study. Am Rev Respir Dis (1985) 0.84

Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patients. Am J Clin Nutr (1986) 0.84

CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion. J Immunol (1999) 0.84

The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function. Blood (1996) 0.84

Invariant chain controls H2-M proteolysis in mouse splenocytes and dendritic cells. J Exp Med (2000) 0.84

Isolation and characterization of a possible new protein marker for differential diagnosis between metastatic carcinoma and mesothelioma cells in serous effusions: preliminary findings. Cancer Detect Prev (1985) 0.84

Depression after lung transplantation: causes and treatment. Lung (2007) 0.84

Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia. Ann Rheum Dis (2004) 0.84

Alterations in high-density lipoprotein subfractions during postprandial lipidaemia induced by fat with and without ethanol. Clin Sci (Lond) (1988) 0.83

Smoking-related lung diseases: a clinical perspective. Eur Respir J (2010) 0.83

Circulating adhesion molecules in cystic fibrosis. Am J Respir Crit Care Med (1998) 0.83

[Fascicular ventricular tachycardia]. Ital Heart J Suppl (2001) 0.83

Recognition of human T-leukemia virus (HTLV-1) envelope by human CD4+ T-cell lines from HTLV-1 seronegative individuals: specificity and clonal heterogeneity. Blood (1995) 0.83

Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group. Prog Clin Biol Res (1989) 0.83

Influence of carbon sources and C/N ratio on EPS production in anaerobic sequencing batch biofilm reactors for wastewater treatment. Bioresour Technol (2009) 0.83

Observation of the semileptonic decays B-->D*tau-nutau and evidence for B-->Dtau-nutau. Phys Rev Lett (2008) 0.83

A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome. Hum Gene Ther (2009) 0.82

Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study. Respir Med (2007) 0.82